AWA
BNGO icon

Arete Wealth Advisors’s Bionano Genomics BNGO Stock Holding History

Arete Wealth Advisors’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-36
Closed -$13K – 529
2023
Q2 		$13K Sell
36
-26
-42% -$11.7K ﹤0.01% 659
2023
Q1 		$41K Hold
62
– – ﹤0.01% 626
2022
Q4 		$54.7M Buy
62
+43
+226% +$54.1K ﹤0.01% 601
2022
Q3 		$21K Buy
+19
New +$25.1K ﹤0.01% 570

Other funds holding BNGO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $149B AUM 24.71% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $299B AUM 28.69% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Arete Wealth Advisors's BNGO Position: Q3 2023 in Review

Arete Wealth Advisors sold out of Bionano Genomics (BNGO) in Q3 2023, closing a stake of 36 shares — an estimated $13K sold.

Arete Wealth Advisors first reported a position in BNGO in Q3 2022 and held it in 4 quarters. The position peaked at $54.7M in Q4 2022. 46 funds tracked by Wall St. Rank hold BNGO as of Q3 2023.

  • Arete Wealth Advisors reported no remaining Bionano Genomics position as of Q3 2023 after selling out during the quarter.
  • Arete Wealth Advisors sold 36 Bionano Genomics shares in Q3 2023, an estimated $13K.
  • Arete Wealth Advisors first reported a position in Bionano Genomics in Q3 2022 and held it in 4 quarters.
  • Arete Wealth Advisors's Bionano Genomics position peaked at $54.7M in Q4 2022.
  • 46 funds tracked by Wall St. Rank held Bionano Genomics as of Q3 2023.

Based on Arete Wealth Advisors's 13F filing for Q3 2023, filed 30 Oct 2023.